4519 · CHUGAI PHARMACEUTICAL CO., LTD. · Financials

7,148 JPY +2 (+0.03%) At close · Nov 12

Rebalance outlook locked

Market Cap

11.76T JPY

1.65B

Volume · Nov 12 2.42M Avg daily vol (3M) 3.05M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Revenue

1.26T +7.5%

FY2025

Net Income

434.01B +12.1%

FY2025

Gross Margin

71.09% +0.1pp

FY2025

Operating Margin

47.6% +1.3pp

FY2025

Operating Cash Flow

386.28B -13.7%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue JPY	-0.1%	+9.8%	—	1.26T	1.17T	1.11T	1.26T	999.76B	786.95B	686.18B
Cost of Revenue JPY	-8.6%	+5.9%	—	363.69B	339.41B	413.31B	476.25B	338.15B	273.47B	266.07B
Gross Profit JPY	+4.5%	+11.7%	—	894.25B	831.2B	698.06B	783.7B	661.61B	513.48B	420.11B
Operating Income JPY	+3.9%	+14.7%	—	598.83B	542B	439.17B	533.31B	421.9B	301.23B	210.6B
Pretax Income JPY	+4.0%	+14.9%	—	597.81B	543.03B	443.82B	531.17B	419.39B	298.19B	207.89B
Income Tax JPY	+1.5%	+14.4%	—	163.79B	155.72B	118.35B	156.74B	116.39B	83.46B	50.33B
Net Income JPY	+5.0%	+15.1%	—	434.01B	387.32B	325.47B	374.43B	303B	214.73B	157.56B

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.